Polyester Dendritic Systems for Drug Delivery Applications: Design, Synthesis, and Characterization
- 24 April 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 13 (3), 443-452
- https://doi.org/10.1021/bc010102u
Abstract
Attachment of drugs to high molecular weight polymers can significantly improve both tumor targeting and therapeutic efficacy due to the enhanced permeability and retention effect observed in tumor tissue. However, the commercial availability of well-defined water-soluble polymeric systems with narrow polydispersities that are biocompatible, nontoxic, and nonimmunogenic is rather limited. To address this need, we have investigated dendritic polymers as promising scaffolds for the preparation of new soluble polymeric drug carriers due to their well-defined molecular architecture and their multiplicity of surface sites. Herein we show the design and synthesis of dendritic polyester systems based on the monomer unit 2,2-bis(hydroxymethyl)propanoic acid as a possible versatile drug carrier. The potent anticancer drug doxorubicin was attached via a pH-sensitive linkage to one of the carriers presented, demonstrating the feasibility of using these polyester dendritic structures to prepare a viable polymer−drug conjugate.Keywords
This publication has 10 references indexed in Scilit:
- HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of actionEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Dendrimers:Journal of Controlled Release, 2000
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000
- Branched biodegradable polyesters for parenteral drug delivery systemsJournal of Controlled Release, 2000
- Polymeric drugs based on conjugates of synthetic and natural macromoleculesJournal of Controlled Release, 2000
- Poly(ethylene glycol) Conjugated Drugs and Prodrugs: A Comprehensive ReviewCritical Reviews in Therapeutic Drug Carrier Systems, 2000
- Enzyme-Prodrug Strategies for Cancer TherapyPublished by Springer Nature ,1999
- Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fateJournal of Controlled Release, 1998
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992
- Structure and properties of pharmacologically active polymersJournal of Polymer Science: Polymer Symposia, 1975